Literature DB >> 10341362

The role of microglia and macrophages in the pathophysiology of the CNS.

G Stoll1, S Jander.   

Abstract

Microglia are a major ghal component of the central nervous system (CNS) and are extremely sessile. Only a subtype, the perivascular microglia, are regularly replaced from the bone marrow in adult animals. Microglia respond to virtually any, even minor pathological events in the CNS. In most pathological settings microglia are aided by infiltrating hematogenous macrophages. Upon activation microglia and macrophages share most phenotypical markers and can exert similar effector functions. After transection of a CNS fibre tract microglia are insufficiently activated and hematogenous macrophages do not significantly enter the degenerating nerve stump. Thereby myelin debris that contains neurite outgrowth inhibiting activity persists for long time. This is in sharp contrast to the peripheral nervous system in which hematogenous macrophages are rapidly recruited in response to axotomy and clear myelin debris allowing regrowth of axons from the proximal stump. However, CNS lesion paradigms with breakdown of the blood-brain barrier such as cerebral ischemia, brain abscesses and stab wounds elicit prompt microglial activation, macrophage recruitment and debris clearance. There is increasing evidence that microglia play an active part in degenerative CNS diseases. In Alzheimer's disease activated microglia appear to be involved in plaque formation. In experimental globoid cell dystrophy T-cell independent induction of major histocompatibility complex class II molecules on microglia accelerates demyelination. In autoimmune diseases microglia probably have dual functions. Microglia present antigen to infiltrating T cells and exert effector functions thereby locally augmenting immune responses. On the other hand, microglia have the capacity to downregulate T cell responses. In the human acquired immunodeficiency syndrome (AIDS) virus infected macrophages probably introduce the virus to the CNS and in concert with microglia are involved in the pathophysiology of the AIDS dementia complex.

Entities:  

Mesh:

Year:  1999        PMID: 10341362     DOI: 10.1016/s0301-0082(98)00083-5

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  152 in total

1.  Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS).

Authors:  M E Duddy; G Dickson; S A Hawkins; M A Armstrong
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

2.  Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool.

Authors:  Benoît Chénais; Hamid Morjani; Jean-Claude Drapier
Journal:  J Neurochem       Date:  2002-05       Impact factor: 5.372

Review 3.  Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors.

Authors:  Kyoungho Suk; Jiyeon Ock
Journal:  Inflammopharmacology       Date:  2011-12-22       Impact factor: 4.473

4.  Shenqi fuzheng injection attenuates irradiation-induced brain injury in mice via inhibition of the NF-κB signaling pathway and microglial activation.

Authors:  Jian Zhang; Fan Tong; Qian Cai; Ling-juan Chen; Ji-hua Dong; Gang Wu; Xiao-rong Dong
Journal:  Acta Pharmacol Sin       Date:  2015-11       Impact factor: 6.150

5.  Astrocytes phagocytose focal dystrophies from shortening myelin segments in the optic nerve of Xenopus laevis at metamorphosis.

Authors:  Elizabeth A Mills; Chung-ha O Davis; Eric A Bushong; Daniela Boassa; Keun-Young Kim; Mark H Ellisman; Nicholas Marsh-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

6.  Up-regulation of TNFalpha in DRG satellite cells following lumbar facet joint injury in rats.

Authors:  Masayuki Miyagi; Seiji Ohtori; Tetsuhiro Ishikawa; Yasuchika Aoki; Tomoyuki Ozawa; Hideo Doya; Tomoko Saito; Hideshige Moriya; Kazuhisa Takahashi
Journal:  Eur Spine J       Date:  2006-04-29       Impact factor: 3.134

7.  Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.

Authors:  Issam El Ghazi; Wen S Sheng; Shuxian Hu; Brian G Reilly; James R Lokensgard; R Bryan Rock; Phillip K Peterson; George L Wilcox; Ian M Armitage
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-25       Impact factor: 4.147

Review 8.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

9.  A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3.

Authors:  Tony Frugier; Nadia L Mitchell; Imke Tammen; Peter J Houweling; Donald G Arthur; Graham W Kay; Otto P van Diggelen; Robert D Jolly; David N Palmer
Journal:  Neurobiol Dis       Date:  2007-09-29       Impact factor: 5.996

10.  Inhibition of inducible NO synthase, cyclooxygenase-2 and interleukin-1beta by torilin is mediated by mitogen-activated protein kinases in microglial BV2 cells.

Authors:  Y Choi; M K Lee; S Y Lim; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.